Literature DB >> 6358923

Long-term evaluation of children with nephrotic syndrome and focal segmental glomerular sclerosis.

A Tejani, A D Nicastri, D Sen, C K Chen, K Phadke, O Adamson, K M Butt.   

Abstract

We studied the long-term outcome of a group of children with the nephrotic syndrome who showed the histological lesion of focal segmental glomerular sclerosis (FSGS) during the course of their illness. Of 25 such children studied, a complete follow-up ranging from 3 to 19 years was available in 24. Two distinct groups could be identified. Patients in the first group were characterized by steroid resistance (SR) from the onset, whereas those in the second group were initially steroid sensitive (SS), and had the histological lesion of minimal change which, over time, evolved into FSGS. SR patients had a mean age of 7.7 +/- 3.7 years compared to SS patients who were 3.5 +/- 2.5 years old (p less than 0.01). There were more females (11 of 14) in the SR group than in the SS group (3 of 10; p less than 0.02). The incidence of hematuria was higher in the SR patients (9 of 14) than SS patients (2 of 10; p less than 0.05). SR patients also exhibited a greater degree of growth retardation at the end of the follow-up period (9 of 13 compared to 1 of 8 SS patients; p less than 0.02). SR patients reached end-stage renal failure earlier (2.3 +/- 1.3 years) than SS patients (10 +/- 5.8 years; p less than 0.01) after the initial biopsy. Of the 13 kidney transplanted into 9 SR patients, recurrence of FSGS was noted in two allografts. Of the 4 kidneys transplanted into 2 SS patients, recurrence was seen in 1. The overall recurrence rate of FSGS in allografts was 17.6%. Our study suggests that the two varieties of FSGS occurring in nephrotic patients may be distinct nosologic entities rather than a single disease with varied manifestations.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6358923     DOI: 10.1159/000183086

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  22 in total

1.  Focal glomerulosclerosis in children: an Argentinian experience.

Authors:  A Tufro-McReddie; E Alvarez; E Arrizurieta; H Repetto
Journal:  Pediatr Nephrol       Date:  1992-03       Impact factor: 3.714

2.  Focal glomerulosclerosis treated with heparin.

Authors:  D R Lines; M Coleman; A Gallus
Journal:  Arch Dis Child       Date:  1989-06       Impact factor: 3.791

3.  Predictive factors of chronic kidney disease in primary focal segmental glomerulosclerosis.

Authors:  Marcelo M Abrantes; Luis Sergio B Cardoso; Eleonora M Lima; José M Penido Silva; José S Diniz; Eduardo A Bambirra; Eduardo A Oliveira
Journal:  Pediatr Nephrol       Date:  2006-05-30       Impact factor: 3.714

4.  Rituximab treatment for posttransplant lymphoproliferative disorder (PTLD) induces complete remission of recurrent nephrotic syndrome.

Authors:  Kandai Nozu; Kazumoto Iijima; Masato Fujisawa; Atsuko Nakagawa; Norishige Yoshikawa; Masafumi Matsuo
Journal:  Pediatr Nephrol       Date:  2005-08-16       Impact factor: 3.714

5.  Primary focal segmental glomerular sclerosis in children: clinical course and prognosis.

Authors:  Kyung Hoon Paik; Bum Hee Lee; Hee Yeon Cho; Hee Gyung Kang; Il Soo Ha; Hae Il Cheong; Dong-Kyu Jin; Kyung Chul Moon; Yong Choi
Journal:  Pediatr Nephrol       Date:  2006-10-21       Impact factor: 3.714

6.  Steroid-resistant nephrotic syndrome: long-term evolution after sequential therapy.

Authors:  Antonia Peña; Juan Bravo; Marta Melgosa; Carlota Fernandez; Carmen Meseguer; Laura Espinosa; Angel Alonso; M Luz Picazo; Mercedes Navarro
Journal:  Pediatr Nephrol       Date:  2007-09-18       Impact factor: 3.714

7.  Efficacy of methylprednisolone pulse therapy in steroid-resistant nephrotic syndrome.

Authors:  Kazuetsu Mori; Masataka Honda; Masahiro Ikeda
Journal:  Pediatr Nephrol       Date:  2004-08-18       Impact factor: 3.714

8.  Minimal change disease with IgM+ immunofluorescence: a subtype of nephrotic syndrome.

Authors:  Sarah J Swartz; Karen W Eldin; M John Hicks; Daniel I Feig
Journal:  Pediatr Nephrol       Date:  2009-02-14       Impact factor: 3.714

9.  Sodium dodecyl sulphate polyacrylamide gel electrophoresis of urinary proteins in steroid-responsive and steroid-resistant nephrotic syndrome in children.

Authors:  G Ramjee; H M Coovadia; M Adhikari
Journal:  Pediatr Nephrol       Date:  1994-12       Impact factor: 3.714

10.  Cyclosporin A treatment in children with minimal change nephrotic syndrome and focal segmental glomerulosclerosis.

Authors:  J Brodehl; M Brandis; U Helmchen; P F Hoyer; R Burghard; J H Ehrich; R B Zimmerhackl; W Klein; K Wonigeit
Journal:  Klin Wochenschr       Date:  1988-11-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.